Latest Breaking News On - Kajal jaddoo - Page 1 : comparemela.com

GlobalData : IGNAZ trial interim results highlight HI-Bio's potential to differentiate in IgAN space, says GlobalData

31 May, 2024 IGNAZ trial interim results highlight HI-Bio s potential to differentiate in IgAN space, says GlobalData Share .

Kajal-jaddoo
European-renal-association
Human-immunology-bioscience
Senior-pharma-analyst

GlobalData : APPLAUSE-IgAN trial interim analysis highlights Novartis' potential to differentiate in IgAN space, says GlobalData

25 Apr, 2024 APPLAUSE-IgAN trial interim analysis highlights Novartis potential to differentiate in IgAN space, says GlobalData Share .

Kajal-jaddoo
Novartis
World-congress
Senior-pharma-analyst
Chinook-therapeutics
Markets

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space

In a recent quarterly update, AstraZeneca revealed that it removed tozorakimab from its phase 2 pipeline for diabetic kidney disease (DKD).

Kajal-jaddoo
Astrazeneca
Markets-amp-regulations
Bio-developments
Pipelines
Emerging-markets
Astrazeneca
Kidney-disease
Diabetes
Pharmaceutical-industry

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space - Pharma News

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Kajal-jaddoo
Astrazeneca
Senior-pharma-analyst

GlobalData : Positive post hoc analysis of SCORED trial to bolster Inpefa use for heart failure, says GlobalData -November 22, 2023 at 01:46 am EST

22 Nov, 2023 Positive post hoc analysis of SCORED trial to bolster Inpefa use for heart failure, says GlobalData Share .

United-states
American
Kajal-jaddoo
American-heart-association-scientific-session
Lexicon-pharmaceutical
Senior-pharma-analyst
Markets